Lipid profiles (in mg/dL) *d4T       AZT TDF
N (%) COR N (%) p-value OR (95% CI)  N (%) p-value OR (95 CI)
TC>200 3 (33.3) 1.00 12 (46.2) 0.5 1.7(0.4-8.4 17(48.6) 0.4 1.9(0.4-8.8)
HDL-c<40 2 (22.2) 1.00 6 (23.1) 0.95 1.05(0.2-6.5) 8(22.8) 1.0 1.0(0.2-6.0)
LDL-c >130 3 (33.3) 1.00 10 (38.5) 0.6 1.3(0.3-6.2) 15(42.9) 0.4 1.5(0.3-7.0)
  TG>150 1 (11.1) 1.00 11 (42.3) 0.1 5.8 (0.6-54.0) 16(45.7) 0.1 6.7(0.8-59.8)
TC/HDL-C >5 1 (11.1) 1.00 7 (26.9) 0.4 2.95(0.3-8.3) 11(31.4) 0.3 3.7(0.4- 33.0)
OR = odds ratio,*reference group, TC= Total Cholesterol, HDL-c= High Density Lipoprotein -Cholesterol, LDL-c= Low Density Lipoprotein-Cholesterol, TG= Triglyceride, d4T = stavudine , AZT = zidovudine, TDF = Tenofovir Disoproxil Fumarate
Table 4: Changes in lipid profile of ART participants by NRTIs regimens at TikurAnbesa hospital, Addis Ababa-Ethiopia, 2013.
Goto home»